[Adaptol in the treatment of ADHD].
Effectiveness of adaptol, a non-benzodiazepine tranquilizer, in the treatment of ADHD has been studied. The use of adaptol in dosage 500 mg 2 times daily during one month resulted in the decrease of hyperactivity and impulsivity and did not exert any influence on attention and reaction time. The authors emphasize the importance of this fact due to its relation to side-effects which are often seen in the treatment with benzodiazepine tranquilizers. It has been concluded that adaptol may be used in the treatment of ADHD as a monotherapy in cases with predominance of hyperactivity/impulsivity and as a complex therapy in other diseases especially in the combination of ADHD and anxiety disorders.
Chutko
L S
LS
Surushkina
S Iu
SIu
Nikishena
I S
IS
Iakovenko
E A
EA
Anisimova
T I
TI
Sergeev
A V
AV
D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001288:Attention / Q000187:drug effects* / Q000502:physiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology; D001736:Biureas; D002648:Child; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D009483:Neuropsychological Tests; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D001736:Biureas; D014149:Tranquilizing Agents; C015979:mebikar